444 related articles for article (PubMed ID: 31307501)
1. A dose-ranging, parallel group, split-face, single-blind phase II study of light emitting diode-red light (LED-RL) for skin scarring prevention: study protocol for a randomized controlled trial.
Nguyen JK; Weedon J; Jakus J; Heilman E; Isseroff RR; Siegel DM; Jagdeo JR
Trials; 2019 Jul; 20(1):432. PubMed ID: 31307501
[TBL] [Abstract][Full Text] [Related]
2. A single-blind, dose escalation, phase I study of high-fluence light-emitting diode-red light (LED-RL) on human skin: study protocol for a randomized controlled trial.
Ho D; Kraeva E; Wun T; Isseroff RR; Jagdeo J
Trials; 2016 Aug; 17():385. PubMed ID: 27484782
[TBL] [Abstract][Full Text] [Related]
3. Light emitting diode-red light for reduction of post-surgical scarring: Results from a dose-ranging, split-face, randomized controlled trial.
Kurtti A; Nguyen JK; Weedon J; Mamalis A; Lai Y; Masub N; Geisler A; Siegel DM; Jagdeo JR
J Biophotonics; 2021 Jul; 14(7):e202100073. PubMed ID: 33788987
[TBL] [Abstract][Full Text] [Related]
4. A single-blind, dose-escalation, phase I study of high-fluence light-emitting diode-red light on Caucasian non-Hispanic skin: study protocol for a randomized controlled trial.
Wang EB; Kaur R; Nguyen J; Ho D; Austin E; Maverakis E; Li CS; Hwang ST; Isseroff RR; Jagdeo J
Trials; 2019 Mar; 20(1):177. PubMed ID: 30894210
[TBL] [Abstract][Full Text] [Related]
5. Safety of light emitting diode-red light on human skin: Two randomized controlled trials.
Jagdeo J; Nguyen JK; Ho D; Wang EB; Austin E; Mamalis A; Kaur R; Kraeva E; Schulman JM; Li CS; Hwang ST; Wun T; Maverakis E; Isseroff RR
J Biophotonics; 2020 Mar; 13(3):e201960014. PubMed ID: 31483941
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Prevents High Fluence Red Light-Emitting Diode Reactive Oxygen Species-Mediated Photoinhibition of Human Skin Fibroblast Migration.
Mamalis A; Koo E; Isseroff RR; Murphy W; Jagdeo J
PLoS One; 2015; 10(10):e0140628. PubMed ID: 26488596
[TBL] [Abstract][Full Text] [Related]
7. High-Fluence Light-Emitting Diode-Generated Red Light Modulates the Transforming Growth Factor-Beta Pathway in Human Skin Fibroblasts.
Mamalis A; Jagdeo J
Dermatol Surg; 2018 Oct; 44(10):1317-1322. PubMed ID: 29846344
[TBL] [Abstract][Full Text] [Related]
8. High fluence light emitting diode-generated red light modulates characteristics associated with skin fibrosis.
Mamalis A; Koo E; Garcha M; Murphy WJ; Isseroff RR; Jagdeo J
J Biophotonics; 2016 Dec; 9(11-12):1167-1179. PubMed ID: 27174640
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial.
Fan D; Xia Q; Wu S; Ye S; Liu L; Wang W; Guo X; Liu Z
Trials; 2018 Mar; 19(1):155. PubMed ID: 29499740
[TBL] [Abstract][Full Text] [Related]
10. Visible Red Light Emitting Diode Photobiomodulation for Skin Fibrosis: Key Molecular Pathways.
Mamalis A; Siegel D; Jagdeo J
Curr Dermatol Rep; 2016; 5():121-128. PubMed ID: 27182462
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light.
Mamalis A; Koo E; Tepper C; Jagdeo J
J Biophotonics; 2019 May; 12(5):e201800207. PubMed ID: 30182520
[TBL] [Abstract][Full Text] [Related]
12. Light emitting diode-generated blue light modulates fibrosis characteristics: fibroblast proliferation, migration speed, and reactive oxygen species generation.
Mamalis A; Garcha M; Jagdeo J
Lasers Surg Med; 2015 Feb; 47(2):210-5. PubMed ID: 25655579
[TBL] [Abstract][Full Text] [Related]
13. Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls.
Karmisholt KE; Banzhaf CA; Glud M; Yeung K; Paasch U; Nast A; Haedersdal M
Br J Dermatol; 2018 Dec; 179(6):1307-1314. PubMed ID: 30101519
[TBL] [Abstract][Full Text] [Related]
14. Light-emitting diode-generated red light inhibits keloid fibroblast proliferation.
Mamalis A; Jagdeo J
Dermatol Surg; 2015 Jan; 41(1):35-9. PubMed ID: 25485805
[TBL] [Abstract][Full Text] [Related]
15. The Combination of Resveratrol and High-Fluence Light Emitting Diode-Red Light Produces Synergistic Photobotanical Inhibition of Fibroblast Proliferation and Collagen Synthesis: A Novel Treatment for Skin Fibrosis.
Mamalis A; Jagdeo J
Dermatol Surg; 2017 Jan; 43(1):81-86. PubMed ID: 28027199
[TBL] [Abstract][Full Text] [Related]
16. High-fluence light emitting diode-red light inhibits cell cycle progression in human dermal fibroblasts.
Masub N; Austin E; Huang A; Jagdeo J
J Biophotonics; 2021 Feb; 14(2):e202000359. PubMed ID: 33038043
[TBL] [Abstract][Full Text] [Related]
17. Interim pressure garment therapy (4-6 mmHg) and its effect on donor site healing in burn patients: study protocol for a randomised controlled trial.
Donovan ML; Muller MJ; Simpson C; Rudd M; Paratz J
Trials; 2016 Apr; 17(1):214. PubMed ID: 27113487
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic effects of low-level light therapy with light-emitting diodes to improve erythema after fractional ablative skin resurfacing: a controlled study.
Wanitphakdeedecha R; Iamphonrat T; Phothong W; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2019 Mar; 34(2):343-351. PubMed ID: 30074109
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
Ferguson MW; Duncan J; Bond J; Bush J; Durani P; So K; Taylor L; Chantrey J; Mason T; James G; Laverty H; Occleston NL; Sattar A; Ludlow A; O'Kane S
Lancet; 2009 Apr; 373(9671):1264-74. PubMed ID: 19362676
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis of human dermal fibroblasts following red light phototherapy.
Austin E; Koo E; Merleev A; Torre D; Marusina A; Luxardi G; Mamalis A; Isseroff RR; Ma'ayan A; Maverakis E; Jagdeo J
Sci Rep; 2021 Apr; 11(1):7315. PubMed ID: 33795767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
